Track topics on Twitter Track topics that are important to you
Scottsdale, Arizona (PRWEB) June 20, 2017
R3 Stem Cell is now offering a free webinar titled "The 411 on Avoiding Surgery with Amniotic Stem Cell Therapy." The webinar will take place Tuesday, June 27th at 8:00 PM EST (5:00 PM PST). Individuals can easily sign up HERE.
The webinar will be hosted by R3 Stem Cell CEO David Greene, MD, MBA. R3's nationwide Centers of Excellence have performed thousands of amniotic stem cell cases nationwide with excellent outcomes reported and no adverse events.
"With the vast amount of misinformation being generated online about amniotic stem cell therapy, we feel it's important to fully present the facts and available evidence. What people will see and hear involves research and scientific information in layman's terms so they will then be able to make an informed decision about their best treatment options!" explained Dr. Greene.
He goes on, "We have seen competitors proliferate myths and inaccurate information without full data about amniotic therapy, and we know the public deserves better."
There is no charge for the webinar, and viewers will receive a large special bonus offer at the end. The webinar is easily viewable on one's computer using the link sent after registering. During the live webinar, individuals will be able to ask as many questions as desired.
Topics covered will include FAQ's, cell counts with amniotic therapy, insurance coverage, IRB research, outcomes with the treatment, comparisons to other methods and much more. People will be educated consumers after viewing the webinar, which will also be available on replay afterwards as well.
For those who would like to sign up for the FREE Webinar: The 411 on Amniotic Stem Cell Treatment, simply visit THIS PAGE and fill in first name and email.
For the original version on PRWeb visit: http://www.prweb.com/releases/r3-stem-cell/amniotic-free-webinar/prweb14438358.htmNEXT ARTICLE
Track and monitor developments in stem cell research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry. BioPort...